Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy

Renfrow, Matthew B.; Mackay, C. Logan; Chalmers, Michael J.; Julian, Bruce A.; Mestecky, Jiri; Kilian, Mogens; Poulsen, Knud; Emmett, Mark R.; Marshall, Alan G.; Novak, Jan
November 2007
Analytical & Bioanalytical Chemistry;Nov2007, Vol. 389 Issue 5, p1397
Academic Journal
IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis. In IgAN, IgA1 molecules with incompletely galactosylated O-linked glycans in the hinge region (HR) are present in mesangial immunodeposits and in circulating immune complexes. It is not known whether the galactose deficiency in IgA1 proteins occurs randomly or preferentially at specific sites. We have previously demonstrated the first direct localization of multiple O-glycosylation sites on a single IgA1 myeloma protein by use of activated ion-electron capture dissociation (AI-ECD) Fourier transform ion cyclotron resonance (FT-ICR) tandem mass spectrometry. Here, we report the analysis of IgA1 O-glycan heterogeneity by use of FT-ICR MS and liquid chromatography FT-ICR MS to obtain unbiased accurate mass profiles of IgA1 HR glycopeptides from three different IgA1 myeloma proteins. Additionally, we report the first AI-ECD fragmentation on an individual IgA1 O-glycopeptide from an IgA1 HR preparation that is reproducible for each IgA1 myeloma protein. These results suggest that future analysis of IgA1 HR from IgAN patients and normal healthy controls should be feasible.


Related Articles

  • Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Novak, Jan; Julian, Bruce; Mestecky, Jiri; Renfrow, Matthew // Seminars in Immunopathology;May2012, Vol. 34 Issue 3, p365 

    IgA nephropathy, described in 1968 as IgA-IgG immune-complex disease, is an autoimmune disease. Galactose-deficient IgA1 is recognized by unique autoantibodies, resulting in the formation of pathogenic immune complexes that ultimately induce glomerular injury. Thus, formation of the...

  • Determination of potential urine biomarkers of kidney disease by LC-MS / MS. Vojtova, L.; Přikryl, P.; Hrušková, Z.; Vokurka, M.; Tesař, V.; Zima, T. // Biochemia Medica;2014 Supplement, Vol. 24, pS76 

    Background: Proteinuria may be caused by either increased glomerular basement membrane permeability, or by impairment of secretion-reabsorption tubular processes. It is often used as a surrogate marker in monitoring and predicting outcome in patients with chronic kidney disease but it is...

  • Urinary Prognostic Biomarkers and Classification of IgA Nephropathy by High Resolution Mass Spectrometry Coupled with Liquid Chromatography. Kalantari, Shiva; Rutishauser, Dorothea; Samavat, Shiva; Nafar, Mohsen; Mahmudieh, Leyla; Rezaei-Tavirani, Mostafa; Zubarev, Roman A. // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    IgA nephropathy is the most common cause of primary glomerulonephritis. There are different pathologic biopsy-based scoring systems in use, but there is no consensus among nephrologists yet regarding the best classification method. Our aim was to test urine proteomics as a non-invasive method...

  • Immunopathogenesis of IgAN. Barratt, Jonathan; Smith, Alice; Molyneux, Karen; Feehally, John // Seminars in Immunopathology;2007, Vol. 29 Issue 4, p427 

    The defining hallmark of IgA nephropathy (IgAN) is deposition of polymeric IgA1 in the glomerular mesangium accompanied by a mesangial proliferative glomerulonephritis. The mechanisms involved in mesangial polymeric IgA1 deposition and the initiation of inflammatory glomerular injury remain...

  • Does tonsillectomy have a role in the treatment of patients with immunoglobulin A nephropathy? Zand, Ladan; Fervenza, Fernando C. // Nephrology Dialysis Transplantation;Aug2014, Vol. 29 Issue 8, p1456 

    No abstract available.

  • IgA Nephropathy: Clinical Significance of Urinary Proteins/Polypeptides Characterization. Bazzi, Claudio // Current Proteomics;Oct2009, Vol. 6 Issue 3, p179 

    IgA nephropathy (IgAN), the most frequent type of glomerulonephritis, is characterized at biopsy by a wide variability of functional, proteinuric and histologic features; about 30% of patients progress to end stage renal disease (ESRD). Baseline proteinuria is one of the main predictors of...

  • The complex of immunoglobulin A and uromodulin as a diagnostic marker for immunoglobulin A nephropathy. Obara, Takashi; Mizoguchi, Sadaaki; Shimozuru, Yasunori; Sato, Toshitaka; Hotta, Osamu // Clinical & Experimental Nephrology;Oct2012, Vol. 16 Issue 5, p713 

    Background: The only tool to diagnose immunoglobulinn A nephropathy (IgAN) is renal biopsy which requires hospitalization; moreover, renal biopsy has a risk of critical bleeding. Therefore, a non-invasive method for accurate diagnosis of IgAN is desirable and a must-to-have tool for the clinics....

  • CELL BIOLOGY - IMMUNOLOGY - PATHOLOGY Clinical significance of costimulatory molecules CD80/CD86 expression in IgA nephropathy. Qiong Wu; Jinde, Kiichiro; Endoh, Masayuki; Sakai, Hideto // Kidney International;Mar2004, Vol. 65 Issue 3, p888 

    Clinical significance of costimulatory molecules CD80/CD86 expression in IgA nephropathy. Background. IgA nephropathy (IgAN) is the most common form of human glomerulonephritis. Tubulointerstitial inflammation with infiltration of mononuclear cells plays an important role in the progression of...

  • IgA nephropathy: Immune mechanisms beyond IgA mesangial deposition. Rifai, A // Kidney International;Aug2007, Vol. 72 Issue 3, p239 

    IgA nephropathy is attributable to mesangial IgA immune complex deposition. The pathogenic potential of frequently colocalized IgG deposits may depend on polarized T-helper cytokines that modulate Fcγ receptors of infiltrating macrophages, leading to either activation or inhibition that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics